Faculty profile

Guillaume Marquis-Gravel

ResearcherMedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Guillaume Marquis-Gravel

Researcher

Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
52 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

105

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Acetylsalicylic Acid Antiplatelet Therapy Bleeding Coronary Artery Disease Myocardial Infarction P2y12 Receptor Inhibitor Patient-Oriented Trial Pragmatic Trial

Latest papers

A Novel Approach for Catheter Knots and Kinks Using a Grasping Device.
JACC. Case reports · 2026 · senior author
Clopidogrel Monotherapy Is Enough for Most Stable Patients With Coronary Artery Disease After Percutaneous Coronary Intervention.
The Canadian journal of cardiology · 2026 · first author
Automated assessment of right ventricular systolic function from coronary angiograms with video-based artificial intelligence algorithms: development, validation, comparison against humans, and prospective deployment.
European heart journal. Digital health · 2026

All 78 publications

Latest funding

Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial
CIHR · 2024 · Nominated PI
$6,972,975
ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a pragmatic, adaptive, patient-oriented randomized controlled trial
CIHR · 2023 · Nominated PI
$956,250

All 2 grants and awards

78 publications.

A Novel Approach for Catheter Knots and Kinks Using a Grasping Device.

Asslo G, Ibrahim R, Thibodeau-Jarry N, Joubert P, Noly PE, Marquis-Gravel G

JACC. Case reports2026Senior author

DOI: 10.1016/j.jaccas.2026.108339 PMID: 42132717

Clopidogrel Monotherapy Is Enough for Most Stable Patients With Coronary Artery Disease After Percutaneous Coronary Intervention.

Marquis-Gravel G, Dostie N, Bagur R

The Canadian journal of cardiology2026First author

DOI: 10.1016/j.cjca.2025.12.049 PMID: 41482147

Automated assessment of right ventricular systolic function from coronary angiograms with video-based artificial intelligence algorithms: development, validation, comparison against humans, and prospective deployment.

Fawzi FZ, Menkovic I, Dostie N, Tremblay-Gravel M, Parent MC, Asslo G, Tanguay JF, Marquis-Gravel G, Ansari M, Barrios JP, Tison GH, Delfrate J, Avram R

European heart journal. Digital health2026

DOI: 10.1093/ehjdh/ztag059 PMID: 42146868

Surgical Risk and Revascularization-An Update.

Marquis-Gravel G, Tong G, Dodd M, Clayton T, Ryan M, Docherty KF, Williams A, Sun J, Fremes SE, Lansky AJ, Velazquez EJ, Perera D, Petrie MC, Rouleau JL

Journal of the Society for Cardiovascular Angiography & Interventions2026First author

DOI: 10.1016/j.jscai.2026.104392 PMID: 42111102

Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis-Time to Reconsider?

Marquis-Gravel G, Makhzoum JP

JAMA network open2026First author

DOI: 10.1001/jamanetworkopen.2026.6587 PMID: 41996122

"Ticagrelor or Prasugrel, Doctor?": A Yet Unresolved Conundrum Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Marquis-Gravel G, Gagnon C

The Canadian journal of cardiology2026First author

DOI: 10.1016/j.cjca.2026.06.002 PMID: 42264369

Timing of Bleeding and Ischemic Events in High-Bleeding Risk Patients Treated With 1-Month DAPT.

Marquis-Gravel G, Cao D, Taylor D, Pocock SJ, Oliva A, Sartori S, Stefanini GG, Urban P, Varenne O, Windecker S, Smits PC, Valgimigli M, Mehran R, Krucoff MW

JACC. Cardiovascular interventions2026First author

DOI: 10.1016/j.jcin.2026.05.027 PMID: 42508848

Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.

Marquis-Gravel G, Tong G, Dodd M, Clayton T, Ryan M, Docherty KF, Williams A, Sun J, Fremes SE, Lansky AJ, Velazquez EJ, Perera D, Petrie MC, Rouleau JL

Journal of the Society for Cardiovascular Angiography & Interventions2025First author

DOI: 10.1016/j.jscai.2025.103820 PMID: 41040436

Adjustment of Antiplatelet Therapy in Patients With Myocardial Infarction Treated Without Revascularization: A Retrospective Cohort Study.

Dostie N, Sarshoghi A, Doucet A, Avram R, Tanguay JF, Marquis-Gravel G

CJC open2025Senior author

DOI: 10.1016/j.cjco.2025.04.012 PMID: 40698304

Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.

Ryan M, Petrie MC, Kontopantelis E, Dodd M, Tong G, Marquis-Gravel G, Docherty KF, Clayton T, Lansky AJ, Mamas MA, Rouleau JL, Velazquez EJ, Perera D

European heart journal2025

DOI: 10.1093/eurheartj/ehaf080 PMID: 40048661

Something wrong or missing on this profile? Suggest a correction

Guillaume Marquis-Gravel

Research

Latest papers

Latest funding

A Novel Approach for Catheter Knots and Kinks Using a Grasping Device.

Clopidogrel Monotherapy Is Enough for Most Stable Patients With Coronary Artery Disease After Percutaneous Coronary Intervention.

Automated assessment of right ventricular systolic function from coronary angiograms with video-based artificial intelligence algorithms: development, validation, comparison against humans, and prospective deployment.

Surgical Risk and Revascularization-An Update.

Low-Dose Aspirin for Cardiovascular Prevention in Giant Cell Arteritis-Time to Reconsider?

"Ticagrelor or Prasugrel, Doctor?": A Yet Unresolved Conundrum Following Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Timing of Bleeding and Ischemic Events in High-Bleeding Risk Patients Treated With 1-Month DAPT.

Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic Dysfunction.

Adjustment of Antiplatelet Therapy in Patients With Myocardial Infarction Treated Without Revascularization: A Retrospective Cohort Study.

Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.

Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial

ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a pragmatic, adaptive, patient-oriented randomized controlled trial

Frequent collaborators

Robert Avram

Maxime Tremblay-Gravel

Jean-Claude Tardif

Jean-Claude Tardif

Jean-Lucien Rouleau

Shamir Mehta

Sanjit Jolly

Marc Jolicoeur

Jonathan Afilalo

Jonathan Afilalo

Matthieu Pelletier-Galarneau

Philippe Joubert

Jean-Paul Makhzoum

Marino Labinaz

Rodrigo Bagur

Rémi Rabasa-Lhoret

Frédéric Lesage

Samer Mansour

Stephen Fremes

Anil Nigam

William Beaubien-Souligny

Abhinav Sharma

William Beaubien-Souligny

William McIntyre

Geoffrey Liu

Frédéric Lesage